Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Debt Ratio (2016)

Gyre Therapeutics (GYRE) has disclosed Debt Ratio for 7 consecutive years, with 0.0 as the latest value for Q3 2016.

  • Quarterly Debt Ratio fell 94.02% to 0.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was 0.0 through Sep 2016, down 94.02% year-over-year, with the annual reading at 0.02 for FY2015, N/A changed from the prior year.
  • Debt Ratio for Q3 2016 was 0.0 at Gyre Therapeutics, down from 0.0 in the prior quarter.
  • The five-year high for Debt Ratio was 0.02 in Q4 2015, with the low at 0.0 in Q3 2016.
  • Average Debt Ratio over 5 years is 0.01, with a median of 0.01 recorded in 2015.
  • The sharpest move saw Debt Ratio surged 120.39% in 2015, then plummeted 94.02% in 2016.
  • Over 5 years, Debt Ratio stood at 0.01 in 2012, then dropped by 18.34% to 0.01 in 2013, then crashed by 51.91% to 0.0 in 2014, then soared by 303.95% to 0.02 in 2015, then tumbled by 96.74% to 0.0 in 2016.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.0, 0.0, and 0.0 for Q3 2016, Q2 2016, and Q1 2016 respectively.